Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial.

Cakir F. B., Yapar O., Canpolat C., Akalin F., Berrak S. G.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, cilt.20, sa.10, ss.2451-7, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 10
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s00520-011-1376-5
  • Dergi Adı: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2451-7
  • Anahtar Kelimeler: Granisetron, Cardiac side effects, Creatine phosphokinase, MODERATELY EMETOGENIC CHEMOTHERAPY, ISCHEMIC MYOCARDIAL INJURY, DOUBLE-BLIND, INTRAVENOUS DOLASETRON, RECEIVING CHEMOTHERAPY, RECEPTOR ANTAGONISTS, DELAYED NAUSEA, TROPONIN-T, CHILDREN, ONDANSETRON
  • Marmara Üniversitesi Adresli: Evet

Özet

Cardiac side effects of granisetron have been studied mostly in adult patients that are using cardiotoxic chemotherapeutics. There is limited evidence in pediatric age group and no information in pediatric oncology patients with non-cardiotoxic chemotherapeutics.